Back to catalogue
№ 368 20 filings · 2021-09-22 → 2026-06-30

SAGA PLC

SAGA
Travel and Leisure Share price 785p Market cap £1.1bn Overall fit 260 /1000

Poor fit for an AI-receiver strategy — Saga has effectively zero direct AI exposure and no plausible AI-driven revenue uplift. It scores modestly on operating leverage (Ocean Cruise) but valuation is at fair value after a 176% one-year rally, and balance sheet leverage remains elevated at 3.2x.

Fair value range 520p–720p Mid case · £900m
Absolute upside -21.1% vs current market cap
Conviction 3/5 confidence in fair call
Supports the call
  • Clean post-Ageas segmental disclosure and visible Cruise forward bookings
  • Explicit medium-term targets with observable deleveraging trajectory
  • Consistent recent pattern of trading updates 'ahead of expectations'
Limits the call
  • Valuation already discounts multi-year deleveraging and cruise cycle
  • Residual £206m insurance broking goodwill and cyclical exposure to over-50s discretionary spend
Methodology

Blended forward P/E on medium-term Underlying earnings + EV/EBITDA cross-check

In one line · bull case

Boutique over-50s travel and insurance-broking specialist with strong Ocean Cruise operating leverage and a clean deleveraging path to <2.0x by 2030.

In one line · biggest risk

A cruise/holidays demand shock (macro, geopolitical or health) into a still-highly-leveraged balance sheet would delay the deleveraging thesis and re-open goodwill impairment risk.

Drivers
AI beneficiary 12 /100
No direct AI exposure; UK travel/insurance business serving over-50s with no AI-driven revenue line.
Operating leverage 62 /100
High fixed-cost owned cruise ships give strong incremental margins on load factor and per diem gains; diluted at group level by broking and central costs.
Earnings vs expectations 68 /100
Consistent recent pattern of 'in line' to 'ahead of expectations' with FY25 delivered ahead of guidance and £10.5m Ageas earn-out triggered early.
Growth momentum 68 /100
Ocean Cruise booked FY27 load factor 92% and per diems +13%; Insurance Broking transition supports return to growth from FY27.
Moat 48 /100
Trusted over-50s brand and 9.7m-strong contactable customer database offer some moat but travel is competitive and insurance broking is now partnership-dependent.
Earnings quality 50 /100
History of large goodwill impairments and exceptional items; cleaner underlying trend post-Ageas but statutory numbers still noisy.
Management quality 58 /100
Successfully executed Ageas transaction, refinanced debt, and delivered on operational targets; still work to do on deleveraging.
Cyclicality 72 /100
Travel and leisure exposure to over-50s discretionary spend plus insurance market cycle; some geopolitical sensitivity flagged for holidays.
Leverage 62 /100
Net Debt £464.7m and 3.2x leverage at May 2026 — falling but still material; no maturities until 2031.
Value-trap signals · 3
  • Multiple large historical Insurance goodwill impairments (£243m cumulative)
  • No dividends since 2020, restricted while leverage above 3.25x
  • Persistent statutory pre-tax losses through FY25 despite underlying profits

SAGA PLC (SAGA) — Investment Research Note

Executive summary

Saga is a UK-focused specialist providing travel, insurance broking and personal finance products to the over-50s market, anchored by two owned ocean cruise ships, a River Cruise fleet, an escorted-holidays business, and a 20-year insurance broking partnership with Ageas (having sold its underwriting arm AICL in July 2025). Across the filing window, the operating trajectory has been a strong recovery in Cruise/Holidays (Ocean Cruise H1 26 load factor 94%, per diem £391, up 8% YoY) alongside a strategic reshape of Insurance from a volatile underwriter into a capital-light broker/affinity model, while Net Debt has fallen from £637m (Jan-24) to £464.7m at May-26 2026-06 AGM. The single most important valuation question today is whether shares — up 176% in twelve months to 608p — have already discounted the £100m Underlying PBT / <2.0x leverage medium-term target for Jan 2030.

Fair value estimate

  • Methodology: blended forward P/E on medium-term earnings + EV/EBITDA cross-check.
  • Assumptions: 2026/27 Underlying PBT of ~£55–65m (continuing operations, guidance "on track for medium-term targets"); a bridge to ~£100m by Jan 2030; Net Debt continuing to fall from £464.7m towards ~£250m by 2030; leverage 3.2x today.
  • Central case: apply 10–12x forward P/E to £75m mid-cycle Underlying earnings (net of ~£20m post-tax finance costs on residual debt) → equity value ~£750–900m.
  • Fair value range: 520p – 720p per share, implying market cap £755m – £1,047m.
  • Mid-point: ~620p / £900m mcap versus current market cap £884m → ~2% upside to mid.
  • Absolute upside/downside: −15% to +18%, mid ~+2%.

Shares are broadly at fair value after a 3x rally over 12 months.

Sector context

  • Sector confirmed: Consumer Discretionary / Travel & Leisure. Insurance broking is a secondary earnings stream but operationally significant.
  • Peer profile: Growth/quality is in line with sector; leverage is above typical peers (3.2x vs typical 1–2x); the cruise business is capital-heavy and cyclical.
  • Listed peers: Carnival, Norwegian Cruise Line (cruise); On the Beach, Jet2 (UK travel); Admiral, Direct Line (insurance broking read-across).

Investment thesis (3 bullets)

  • Ocean Cruise is a genuine boutique niche with pricing power and visible bookings: H1 26 load factor 94%, per diem +8%; forward book at 92% load factor for FY26/27, with commodity and FX hedged out to end-2027 2026-06 AGM; 2025-09 interim. Two owned ships give operating leverage on incremental demand.
  • Insurance simplification removes volatility and unlocks a capital-light growth path: AICL divested to Ageas (July 2025) for ~£57.9m initial + £6.5m earn-out and freed up £242m of investment portfolio; 20-year Affinity Partnership with Ageas went live in 2025 and has already triggered a £10.5m contingent payment 2026-06 AGM; 2025-09 interim.
  • Balance-sheet deleveraging is well underway with no near-term maturities: Net Debt down £104.8m YoY to £464.7m; new £335m HPS term loan matures Jan-2031; leverage 3.2x vs targeted <2.0x by Jan 2030 2026-06 AGM.

Key risks (3 bullets)

  • Cyclicality of cruise/holidays with Middle East geopolitical drag: Management flags "higher proportion of short-haul holidays as a result of the conflict in the Middle East" and holidays passenger numbers "potentially slightly behind" 2026-06 AGM. A demand shock among older, more risk-averse customers would hit occupancy sharply.
  • Elevated financial leverage and 675bps+ term-loan margin: Initial blended pro forma interest rate ~7.6%; finance costs (£50.5m FY25 continuing) still consume much of Trading EBITDA. Any earnings miss delays deleveraging 2025-04 final results.
  • Insurance broking margin compression under partnership model: Group has already impaired £138.3m of Insurance Broking goodwill (FY25), and management has guided to lower margins per policy (~£60 vs prior £74). Home insurance policy sales down 19% H1 26; motor still competitive 2025-09 interim.

Operating leverage

Ocean Cruise is the crown jewel of operating leverage: two capital-heavy assets (carrying value £566.5m), predominantly fixed-cost operating base, and pricing power over a captive repeat-customer base (65% repeat bookings, 85 tNPS). H1 26 Ocean Cruise revenue £130.9m generated Trading EBITDA of £53.2m (~41% margin) 2025-09 interim. Combined with c.£566m of fixed ship assets, a 10–20% revenue surprise from higher per diems (already 13% higher in booked FY27) would drop through at roughly ~55%+ contribution margin — potentially adding ~£15–25m to EBITDA on a modest revenue beat. River Cruise sees similar dynamics on a smaller scale. Insurance Broking, by contrast, is more variable-cost and lower operating leverage post the Ageas transition (marketing/pricing investment scales with volume). Group operating leverage is therefore concentrated in Cruise and is high enough to matter, but total-group leverage is diluted by the broking, publishing and central cost base.

Value-trap signals

  • Historically severe goodwill impairments (£138.3m in FY25 + £104.9m in FY24 + prior charges), reflecting past over-optimism on Insurance economics.
  • Six years of statutory losses before tax (FY24 −£129m; FY25 −£141m loss including discontinued ops).
  • No dividends since 2020 and restricted while leverage >3.25x (RCF) and ship debt deferred amounts outstanding.
  • Mitigants: trajectory in FY26 is materially different — clean, simpler business post-Ageas; management explicitly on track vs medium-term targets; Net Debt genuinely falling.

Earnings vs. expectations

Across the filings, Saga's messaging pattern has been consistent "in line" or "ahead of expectations" beats: FY25 delivered Underlying PBT of £47.8m "ahead of previous guidance" 2026-01 trading update; H1 26 was "ahead of expectations" driven by Travel 2025-09 interim; Jan 2026 trading update explicitly said Underlying PBT would be "ahead of guidance"; and the June 2026 AGM update was "in line with expectations" with a £10.5m contingent payment triggered ahead of schedule. Analyst consensus figures are not cited in the filings, but management guidance beats have been the more reliable signal — a track record of moderate positive surprises during the current recovery phase.

Conviction

3 — Moderate.

  • Supports: clean segmental disclosure post-Ageas; strong forward booking visibility for Cruise (already 93% loaded H1 27); explicit medium-term targets with observable deleveraging.
  • Limits: valuation is a call on 4–5 years of deleveraging and cruise cycle; recent share-price move already discounts a good outcome; potential for cruise demand shock from geopolitics or macro; the insurance goodwill (£206.4m remaining) is not fully de-risked.
Filings consulted · 26

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-06-30Result OF Agm2026-06-30_9645179_result-of-agm.md0.30
  2. 2026-06-30Agm Trading Update2026-06-30_9642963_agm-trading-update.md0.85
  3. 2026-05-26Notice OF Agm Annual Report And Accounts2026-05-26_9585325_notice-of-agm-annual-report-and-accounts.md0.95
  4. 2026-01-29Trading Update2026-01-29_9392520_trading-update.md0.72
  5. 2025-09-242025 26 Interim Results Statement Replacement2025-09-24_9128374_2025-26-interim-results-statement-replacement.md0.77
  6. 2025-09-242025 26 Interim Results Statement2025-09-24_9127407_2025-26-interim-results-statement.md0.77
  7. 2025-06-24Result OF Agm2025-06-24_8945593_result-of-agm.md0.20
  8. 2025-06-24Agm Trading Update2025-06-24_8943854_agm-trading-update.md0.55
  9. 2025-05-20Notice OF Agm2025-05-20_8887468_notice-of-agm.md0.20
  10. 2025-04-09Final Results2025-04-09_8820850_final-results.md0.65
  11. 2025-01-30Trading Update2025-01-30_8712775_trading-update.md0.55
  12. 2024-10-11Interim Results For The Six Months Ended 31 July2024-10-11_8479579_interim-results-for-the-six-months-ended-31-july.md0.58
  13. 2024-06-25Result OF Agm2024-06-25_8277647_result-of-agm.md0.14
  14. 2024-06-25Correction Result OF Agm2024-06-25_8277733_correction-result-of-agm.md0.14
  15. 2024-06-25Agm Trading Update2024-06-25_8275732_agm-trading-update.md0.38
  16. 2024-05-21Notice OF Agm2024-05-21_8211067_notice-of-agm.md0.14
  17. 2024-01-30Trading Update2024-01-30_8011668_trading-update.md0.38
  18. 2023-09-27Interim Results2023-09-27_7779930_interim-results.md0.41
  19. 2023-06-20Agm Trading Update2023-06-20_7582390_agm-trading-update.md0.21
  20. 2023-05-15Notice OF Agm2023-05-15_7526093_notice-of-agm.md0.07
  21. 2023-04-18Annual Report And Accounts And Strategic Report2023-04-18_7463120_annual-report-and-accounts-and-strategic-report.md0.24
  22. 2023-01-24Trading Update2023-01-24_7499690_trading-update.md0.21
  23. 2022-09-27Interim Results2022-09-27_7122952_interim-results.md0.23
  24. 2022-07-05Trading Update2022-07-05_6869816_trading-update.md0.21
  25. 2022-01-27Trading Update2022-01-27_6996520_trading-update.md0.21
  26. 2021-09-22Interim Results2021-09-22_6514112_interim-results.md0.23

This research note was authored by a large language model after reading 20 regulatory filings published between 2021-09-22 and 2026-06-30. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.